General Information
Version
6.5
Revision date
2023-09-21
Product name
Remifentanil Hydrochloride
CAS No.
132539-07-2
REACH No
A
Emergency telephone
800-789-767, +39-02-4555-7031, +39 02-6610-1029
Icons in SDS
Company Information
company name
Merck Life Science S.r.l
e-mail address of the competent person responsible for the Safety Data Sheet
serviziotecnico@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H371
Hazard statements
Code
Statements
H371
May cause damage to organs
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H371 May cause damage to organs (Respiratory system). Reduced Labeling (<= 125 ml) none
Precautionary statements
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. none
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Specific target organ toxicity - single exposure (Category 2), Respiratory system, H371 For the full text of the H-Statements mentioned in this Section, see Section 16.
